Advertisement
Screener

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Payments to Fund Long-term Loans to Related Parties

2.3 / 5 stars · 27/60 Roast Me

IOVANCE BIOTHERAPEUTICS, INC. Payments to Fund Long-term Loans to Related Parties

IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Payments to Fund Long-term Loans to Related Parties of $50.00 thousand for the 78-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.

Discontinued › Cash Flow › Other Cash Flow Items

us-gaap:PaymentsToFundLongtermLoansToRelatedParties · last filed 2014-05-14

  • IOVANCE BIOTHERAPEUTICS, INC. payments to fund long-term loans to related parties for the quarter ending 2013-12-31 was $0.00.
  • IOVANCE BIOTHERAPEUTICS, INC. payments to fund long-term loans to related parties for the quarter ending 2013-09-30 was $0.00.
  • IOVANCE BIOTHERAPEUTICS, INC. payments to fund long-term loans to related parties for the quarter ending 2013-06-30 was $0.00.
  • IOVANCE BIOTHERAPEUTICS, INC. payments to fund long-term loans to related parties for the quarter ending 2013-03-31 was $0.00.
  • IOVANCE BIOTHERAPEUTICS, INC. payments to fund long-term loans to related parties for fiscal 2013 was $0.00.
  • IOVANCE BIOTHERAPEUTICS, INC. payments to fund long-term loans to related parties for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
  • IOVANCE BIOTHERAPEUTICS, INC. payments to fund long-term loans to related parties for fiscal 2011 was $50.00K.
  • IOVANCE BIOTHERAPEUTICS, INC. payments to fund long-term loans to related parties for fiscal 2010 was $0.00.
Period endPayments to Fund Long-term Loans to Related Parties 3 monthPayments to Fund Long-term Loans to Related Parties 6 monthPayments to Fund Long-term Loans to Related Parties 9 monthPayments to Fund Long-term Loans to Related Parties 12 monthPayments to Fund Long-term Loans to Related Parties 51 monthPayments to Fund Long-term Loans to Related Parties 54 monthPayments to Fund Long-term Loans to Related Parties 57 monthPayments to Fund Long-term Loans to Related Parties 60 monthPayments to Fund Long-term Loans to Related Parties 63 monthPayments to Fund Long-term Loans to Related Parties 66 monthPayments to Fund Long-term Loans to Related Parties 69 monthPayments to Fund Long-term Loans to Related Parties 72 monthPayments to Fund Long-term Loans to Related Parties 78 month
2014-03-31$50.00K
10-Q · filed 2014-05-14
2013-12-31$0.00
derived: 10-K 12 month − 3 quarters · filed 2014-03-28
$0.00
derived: sum of 2 quarters · filed 2014-03-28
$0.00
derived: sum of 3 quarters · filed 2014-03-28
$0.00
10-K · filed 2014-03-28
$50.00K
10-K · filed 2014-03-28
2013-09-30$0.00
derived: 10-Q 72 month − 10-Q 69 month · filed 2013-11-14
$0.00
derived: sum of 2 quarters · filed 2013-11-14
$0.00
derived: sum of 3 quarters · filed 2013-11-14
$0.00
derived: sum of 4 quarters · filed 2014-03-28
$50.00K
10-Q · filed 2013-11-14
2013-06-30$0.00
derived: 10-Q 69 month − 10-Q 66 month · filed 2013-10-23
$0.00
derived: sum of 2 quarters · filed 2013-10-23
$0.00
derived: sum of 3 quarters · filed 2014-03-28
$0.00
derived: sum of 4 quarters · filed 2014-03-28
$50.00K
10-Q · filed 2013-10-23
2013-03-31$0.00
10-Q · filed 2013-10-23
$0.00
derived: sum of 2 quarters · filed 2014-03-28
$0.00
derived: sum of 3 quarters · filed 2014-03-28
$0.00
derived: sum of 4 quarters · filed 2014-03-28
$50.00K
10-Q · filed 2013-10-23
2012-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28
$0.00
derived: sum of 2 quarters · filed 2014-03-28
$0.00
derived: sum of 3 quarters · filed 2014-03-28
$0.00
10-K · filed 2014-03-28
$50.00K
10-K · filed 2013-09-23
2012-09-30$0.00
derived: 10-Q 60 month − 10-Q/A 57 month · filed 2013-01-25
$0.00
derived: sum of 2 quarters · filed 2013-01-25
$0.00
10-Q · filed 2013-01-25
$50.00K
derived: sum of 4 quarters · filed 2013-10-23
$50.00K
10-Q · filed 2013-01-25
2012-06-30$0.00
derived: 10-Q/A 57 month − 10-Q 54 month · filed 2012-09-10
$0.00
derived: sum of 2 quarters · filed 2013-10-23
$50.00K
derived: sum of 3 quarters · filed 2013-10-23
$0.00
derived: sum of 4 quarters · filed 2013-10-23
$50.00K
10-Q/A · filed 2012-09-10
2012-03-31$0.00
10-Q · filed 2013-10-23
$50.00K
derived: sum of 2 quarters · filed 2013-10-23
$0.00
derived: sum of 3 quarters · filed 2013-10-23
$0.00
derived: sum of 4 quarters · filed 2013-10-23
$50.00K
10-Q · filed 2012-05-15
2011-12-31$50.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23
$0.00
derived: sum of 2 quarters · filed 2013-09-23
$0.00
derived: sum of 3 quarters · filed 2013-09-23
$50.00K
10-K · filed 2013-09-23
$50.00K
10-K · filed 2012-03-30
2011-09-30-$50.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-01-25
-$50.00K
derived: sum of 2 quarters · filed 2013-01-25
$0.00
10-Q · filed 2013-01-25
2011-06-30$0.00
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-10
$50.00K
10-Q/A · filed 2012-09-10
2011-03-31$50.00K
10-Q · filed 2012-05-15
2010-12-31$0.00
10-K · filed 2012-03-30
2009-12-31$0.00
10-K · filed 2012-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
Immunovant, Inc. (IMVT)United States$7.028B-14.78
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Greenland Mines Ltd (GRML)United States$2.362B